✦ LIBER ✦

Efficacy and tolerability after 24weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV–HCV coinfected subjects

✍ Scribed by Genebat, Miguel; Vera, Francisco; Hernández-Quero, José; Domingo, Pere; Guardiola, José M.; Martínez-Madrid, Onofre; Martínez, Lorena; de la Llana, Francisco García; Sánchez-Villegas, Jorge; Álvarez, Hortensia; Mariño, Ana; Lluch, José F.; Martínez-Pérez, María A.; Marín, Jorge; Ruiz-Mateos, Ezequiel; Leal, Manuel

Book ID: 121666295
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 385 KB
Volume: 104
Category: Article
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2014.01.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

F-02 Incidence and consequences of throm

F-02 Incidence and consequences of thrombocytopenia in 1523 HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin

✍ Cattelan, A.M.; Angeli, E.; Pontali, E.; Gulminetti, R.; Maida, I.; Nasta, P.; V 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

CD81 expression in peripheral blood lymp

CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients

✍ D Micheloud; J González-Nicolás; J Berenguer; R Lorente; P Miralles; JC López; J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

Therapeutical Aspects and Outcome of HIV

Therapeutical Aspects and Outcome of HIV/HCV Coinfected Patients Treated with Pegylated Interferon plus Ribavirin in an Italian Cohort

✍ E. Righi; A. Beltrame; M. Bassetti; V. Lindstrom; G. Mazzarello; C. Dentone; A. 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 226 KB

F-04 Incidence, predictors and managemen

F-04 Incidence, predictors and management strategies of anemia in HIV/HCV coinfected patients treated with PEGylated interferon and ribavirin

✍ Angeli, E.; Cariti, G.; Carosi, G.; Pontali, E.; Cattelan, A.M.; Gulminetti, R.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Simeprevir (TMC435) With Pegylated Inter

Simeprevir (TMC435) With Pegylated Interferon/Ribavirin in Patients Coinfected With HCV Genotype 1 and HIV-1: A Phase 3 Study

✍ Dieterich, D.; Rockstroh, J. K.; Orkin, C.; Gutierrez, F.; Klein, M. B.; Reynes, 📂 Article 📅 2014 🏛 University of Chicago Press 🌐 English ⚖ 430 KB

P.408 Safety and efficacy of a 24-week c

P.408 Safety and efficacy of a 24-week course of pegylated interferon α-2a and ribavirin for the treatment of acute HCV infection in HIV positive patients

✍ S.S.D. Dominguez; J.J.G. Ghosn; A. Schruniger; M. Valantin; A. Simon; D. Bollens 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 282 KB